Press Releases

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial…

Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence

Debiopharm leads investment round for evidence-based digital cancer therapeutic app Mika to empower cancer patients

VivoSense Announces Closing of $25M Series A Financing Round Co-led by Xontogeny and Debiopharm

Debiopharm invests in VeriSIM Life’s $15m series A round to advance AI-enabled drug research

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…

Nucleai and Debiopharm Launch Research Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform